PSMD10 and non-small cell lung carcinoma: Silencing Gankyrin significantly reduced the viability of NSCLC cells (Fig. 3B), and wound-healing assay showed that si-Gankyrin inhibited the migration of NSCLC cells (Fig. 3C).